Injective Price Jumps as Nasdaq Lists Canary Staked INJ ETF

Key takeaways

• Injective rises after Nasdaq lists staked INJ ETF
• New fund combines spot INJ exposure and staking
• Altcoin ETF expansion broadens institutional crypto access

Injective’s INJ token jumped on Nov. 5 after Nasdaq began listing the Canary Staked INJ ETF under the ticker INJC, giving Wall Street investors a new way to gain exposure to the altcoin through a regulated product.

<iframe src=”https://widgets.coincodex.com/w/1bdb9f8a-3b27-4b48-8baa-88ff5922b940?site=coinpaper&mode=light” width=”100%” height=”420” frameborder=”0” referrerpolicy=”no-referrer-when-downgrade” style=”border:0;background:transparent;border-radius:0px;”></iframe>

According to Nasdaq’s official listing notice and Canary’s latest SEC prospectus, the new fund is designed to hold INJ directly while also seeking additional returns through staking rewards. That makes it different from a simple spot-style crypto fund, because the trust is not only tracking the token’s market price but also participating in the Injective network’s proof-of-stake system.

Nasdaq Listing Gives Injective a New Institutional Catalyst

The launch matters because it moves Injective closer to the mainstream investment infrastructure already used by traditional stock and ETF buyers.

Under the prospectus, the trust’s primary goal is to provide exposure to the price of INJ, while its secondary goal is to earn more INJ through staking. In practice, that means investors are buying access to two value drivers at once: the token itself and the yield generated by helping validate transactions on the network.

That structure adds a new chapter to the broader altcoin ETF trend already visible in products tied to Solana and other digital assets. Coinpaper recently covered how a Hong Kong Solana ETF launch arrived even as U.S. SOL funds saw withdrawals, and how Solana ETFs crossed new asset milestones as institutional demand widened beyond Bitcoin.

That context matters because INJC is not appearing in isolation. It is part of a growing effort to package altcoins into vehicles that look more familiar to traditional investors.

Why Staking Exposure Could Make INJC Different

The most important detail is not just that INJ now has an ETF. It is that the product is specifically structured as a staked ETF.

That means investors do not simply gain passive price exposure. The trust is also intended to participate in network staking, potentially generating additional INJ over time. Similar mechanics have already attracted attention in other crypto investment products, especially as issuers search for ways to make altcoin funds more competitive than plain price-tracking vehicles.

For Injective, the listing also reinforces a longer-term thesis around token scarcity and network economics. Earlier this year, Coinpaper highlighted Injective’s INJ Supply Squeeze, a deflation-focused update designed to accelerate supply reduction. A fund that accumulates INJ and stakes it fits naturally into that broader narrative of reduced liquid supply and deeper institutional participation.

The development also arrives just weeks after Grayscale expanded direct token-for-fund exchanges across several altcoin products, another sign that regulated access is becoming more sophisticated.